Cite
MLA Citation
A.C. Embleton et al.. “2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC).” European journal of cancer, vol. 51, n.d., pp. S546–. http://access.bl.uk/ark:/81055/vdc_100030628262.0x00002b